M3 Inc
OTC:MTHRY
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY |
Loading...
|
|
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD |
Loading...
|
|
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
28.6B USD |
Loading...
|
|
| AU |
|
Pro Medicus Ltd
ASX:PME
|
12.3B AUD |
Loading...
|
|
| US |
|
Doximity Inc
NYSE:DOCS
|
4.7B USD |
Loading...
|
|
| SE |
|
Sectra AB
STO:SECT B
|
35.5B SEK |
Loading...
|
|
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
3.9B USD |
Loading...
|
|
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
25.2B CNY |
Loading...
|
|
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
281.4B INR |
Loading...
|
|
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR |
Loading...
|
|
| US |
H
|
Heartflow Inc
NASDAQ:HTFL
|
1.9B USD |
Loading...
|
Market Distribution
| Min | -179.8% |
| 30th Percentile | 21.8% |
| Median | 30.6% |
| 70th Percentile | 42.3% |
| Max | 18 197.9% |
Other Profitability Ratios
M3 Inc
Glance View
M3 Inc. emerged from Japan in the late 1990s, rapidly morphing from a novel digital venture into a formidable player in the global medical information services arena. The company's genesis was rooted in the transformative vision of leveraging web-based platforms to bridge vast distances between healthcare professionals, providing them with timely, accurate information and resources. As the internet began revolutionizing industries, M3 Inc. seized this opportunity, focusing on creating a seamless digital environment that connected pharmaceutical companies with medical professionals. Their flagship offering, M3.com, became a pivotal platform—essentially serving as a nexus where healthcare giants could introduce their latest products and innovations to an audience of medical practitioners, facilitating informed decision-making and nurturing vital industry relationships. Reaching beyond Japanese shores, M3 Inc. strategically expanded its influence into markets in Europe, the United States, and further afield, deftly tailoring its platforms to meet diverse regulatory standards and cultural nuances. Today, its financial vitality is driven by a multifaceted business model. Primarily, M3 derives revenue from pharmaceutical companies and medical device makers who pay for advertising space and market research insights on its network, valuing the direct engagement with physicians it facilitates. Moreover, the company has smartly diversified its portfolio by incorporating online healthcare services and physician recruitment, offering a comprehensive suite of services that cater to the evolving needs of the medical community. By aligning its growth with the digital evolution of the healthcare industry, M3 Inc. continues to solidify its role as a linchpin in the health information ecosystem.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for M3 Inc is 50.4%, which is below its 3-year median of 56.3%.
Over the last 3 years, M3 Inc’s Gross Margin has decreased from 58.5% to 50.4%. During this period, it reached a low of 50.4% on Jan 31, 2026 and a high of 59.3% on Sep 30, 2023.